On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Zero to Three

InstitutionResearch output, impact & collaborations

Zero to Three is a institution indexed in ScholarIQ from OpenAlex.

What is known about Zero to Three?

ScholarIQrecord summary

Zero to Three is a research organisation in Washington, US. OpenAlex records 194 works and 9,565 citations for it.

How many works does Zero to Three have?

ScholarIQindexed works

Zero to Three has 194 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Zero to Three have?

ScholarIQcitation count

Zero to Three has 9,565 citations in the OpenAlex counts ScholarIQ stores.

What is the average h-index at Zero to Three?

ScholarIQavg h-index

Zero to Three has an average h-index of 45 in OpenAlex.

What is the ROR of Zero to Three?

ScholarIQror

The ROR for Zero to Three is on the source record.

What is the OpenAlex record for Zero to Three?

ScholarIQopenalex

The OpenAlex for Zero to Three is on the source record.

Who are the most-cited researchers behind Zero to Three?

ScholarIQtop researchers by citations
1
Wei‐jie Guan · Cystic Fibrosis Research Advances
266 works49,625 citations

What are the most-cited papers on Zero to Three?

ScholarIQmost cited works
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Wenhua Liang, Wei‐jie Guan, Ruchong Chen, Wei Wang, Jianfu Li, Ke Xu, Caichen Li, Qing Ai, Weixiang Lu, Hengrui Liang, Shiyue Li, Jianxing He
The Lancet Oncology. 20204,605 CitationsOPEN ACCESS
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19
Wenhua Liang, Hengrui Liang, Limin Ou, Binfeng Chen, Ailan Chen, Caichen Li, Yimin Li, Wei‐jie Guan, Ling Sang, Jiatao Lu, Yuanda Xu, Guoqiang Chen, Haiyan Guo, Jun Guo, Zisheng Chen, Yi Zhao, Shiyue Li, Nuofu Zhang, Nanshan Zhong, Jianxing He
JAMA Internal Medicine. 20201,521 CitationsOPEN ACCESS
Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis
Wei‐jie Guan, Wenhua Liang, Yi Zhao, Hengrui Liang, Zisheng Chen, Yimin Li, Xiaoqing Liu, Ruchong Chen, Chunli Tang, Tao Wang, Chun‐Quan Ou, Li Li, Pingyan Chen, Ling Sang, Wei Wang, Jianfu Li, Caichen Li, Limin Ou, Bo Cheng, Shan Xiong, Zhengyi Ni, Jie Xiang, Yu Hu, Lei Liu, Hong Shan, Chunliang Lei, Yixiang Peng, Li Wei, Yong Liu, Yahua Hu, Peng Peng, Jianming Wang, Jiyang Liu, Zhong Chen, Gang Li, Zhijian Zheng, Shaoqin Qiu, Jie Luo, Chang-jiang Ye, Shaoyong Zhu, Linling Cheng, Feng Ye, Shiyue Li, Jin-ping Zheng, Nuofu Zhang, Nanshan Zhong, Jianxing He
medRxiv. 2020650 CitationsOPEN ACCESS
Early triage of critically ill COVID-19 patients using deep learning
Wenhua Liang, Jianhua Yao, Ailan Chen, Qingquan Lv, Mark Zanin, Jun Liu, Sook‐San Wong, Yimin Li, Jiatao Lu, Hengrui Liang, Guoqiang Chen, Haiyan Guo, Jun Guo, Rong Zhou, Limin Ou, Niyun Zhou, Hanbo Chen, Fan Yang, Xiao Han, Wenjing Huan, Weimin Tang, Wei‐jie Guan, Zisheng Chen, Yi Zhao, Ling Sang, Yuanda Xu, Wei Wang, Shiyue Li, Ligong Lu, Nuofu Zhang, Nanshan Zhong, Junzhou Huang, Jianxing He
Nature Communications. 2020306 CitationsOPEN ACCESS
Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease
Yumin Zhou, Nanshan Zhong, Xiaochen Li, Shuyun Chen, Jinping Zheng, Dongxing Zhao, Weimin Yao, Rong-Chang Zhi, Liping Wei, HE Bingwen, Xiangyan Zhang, Changli Yang, Ying Li, Fenglei Li, Juan Du, Jianping Gui, Bin Hu, Chunxue Bai, Ping Huang, Gang Chen, Yongjian Xu, Changzheng Wang, Biao Liang, Yinhuan Li, Guoping Hu, Hui Jan Tan, Xianwei Ye, Xi-tao Ma, Yan Chen, Xiwei Hu, Jia Tian, Xiaodan Zhu, Zhe Shi, Xiu‐Fang Du, Minjing Li, Shengming Liu, Ronghuan Yu, Jianping Zhao, Qianli Ma, Canmao Xie, Xiongbin Li, Tao Chen, Yingxiang Lin, Li-zhen Zeng, Changxiu Ye, Weishu Ye, Xiangwen Luo, Lingshan Zeng, Shuqing Yu, Wei‐jie Guan, Pixin Ran
New England Journal of Medicine. 2017294 Citations

How much of the research on Zero to Three is open access?

ScholarIQopen access share
80%OPEN ACCESS
Gold
20%
Green
20%
Hybrid
0%
Bronze
40%
Closed
20%

Related on ScholarIQ

470M+ articles · 14-day free trial